Ideaya Biosciences is a startup based in the United States, most recent round Series-c-plus, 3 tracked investors.
Ideaya Biosciences is a startup founded in 2017 based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 3 investors associated with the company.
Ideaya Biosciences is a clinical-stage precision oncology company that discovers and develops therapies targeting DNA damage response (DDR) pathways and exploiting synthetic lethality, and develops predictive biomarkers to guide patient selection.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.